Bliss GVS Pharma Limited (NSE:BLISSGVS)
India · Delayed Price · Currency is INR 447.20
-20.40 (-4.36%)
Jul 22, 2026, 3:30 PM IST
Bliss GVS Pharma Revenue
In the fiscal year ending March 31, 2026, Bliss GVS Pharma had annual revenue of 9.27B INR with 14.50% growth. Bliss GVS Pharma had revenue of 2.57B in the quarter ending March 31, 2026, with 29.80% growth.
Revenue
9.27B
Revenue Growth
+14.50%
P/S Ratio
5.35
Revenue / Employee
8.97M
Employees
1,033
Market Cap
49.55B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 9.27B | 1.17B | 14.50% |
| Mar 31, 2025 | 8.10B | 394.81M | 5.13% |
| Mar 31, 2024 | 7.70B | 186.57M | 2.48% |
| Mar 31, 2023 | 7.52B | 41.33M | 0.55% |
| Mar 31, 2022 | 7.47B | 1.70B | 29.50% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 48.59B |
| Akums Drugs and Pharmaceuticals | 43.61B |
| Indoco Remedies | 18.45B |
| Aarti Pharmalabs | 18.19B |
| Innova Captab | 16.30B |
| Solara Active Pharma Sciences | 13.69B |
| Orchid Pharma | 8.11B |
| RPG Life Sciences | 7.08B |
Bliss GVS Pharma News
- 18 days ago - Bliss GVS Pharma appoints Rahul Adakmol as CEO effective July 15, 2026 - Business Upturn
- 4 weeks ago - Bliss GVS Pharma announces book closure and record date for dividend payment - Business Upturn
- 4 weeks ago - Bliss GVS Pharma announces Re. 1 final dividend per share for FY 2025-2026 - Business Upturn
- 6 weeks ago - Anupam Rasayan makes Rs 299 per share open offer for Bliss GVS Pharma - Business Upturn
- 6 weeks ago - Bliss GVS Pharma faces Rs 299 per share open offer from Anupam Rasayan - Business Upturn
- 7 weeks ago - Bliss GVS Pharma achieves WHO-GMP compliance for manufacturing facility - Business Upturn
- 2 months ago - Why are Bliss GVS Pharma shares rallying over 15% today? Explained - Business Upturn
- 2 months ago - Bliss GVS Pharma shares jump 7% after Anupam Rasayan announces ₹1,369 crore stake acquisition deal - Business Upturn